- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04213183
Screening and Identifying Hepatobiliary Diseases Via Deep Learning Using Ocular Images
August 16, 2020 updated by: Haotian Lin, Sun Yat-sen University
Artificial Intelligence may provide insight into exploring the potential covert association behind and reveal some early ocular architecture changes in individuals with hepatobiliary disorders.
We conducted a pioneer work to explore the association between the eye and liver via deep learning, to develop and evaluate different deep learning models to predict the hepatobiliary disease by using ocular images.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
1789
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510000
- Zhongshan Ophthalmic Center, Sun Yat-sen Univerisity
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Slit-lamp and retinal fundus images collected from Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-sen University, Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-sen University, Affiliated Huadu Hospital of Southern Medical University, Nantian Medical Centre of Aikang Health Care, and Huanshidong Medical Centre of Aikang Health Care.
Description
Inclusion Criteria:
- The quality of fundus and slit-lamp images should clinical acceptable.
- More than 90% of the fundus image area including four main regions (optic disk, macular, upper and lower retinal vessel archs) are easy to read and discriminate.
- More than 90% of the slit-lamp image area including three main regions (sclera, pupil, and lens) are easy to read and discriminate.
Exclusion Criteria:
- Images with light leakage (>10% of the area), spots from lens flares or stains, and overexposure were excluded from further analysis.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
development dataset 01
Slit-lamp and retinal fundus images collected from Department of Hepatobiliary Surgery of the Third Affiliated Hospital of Sun Yat-sen University.
|
The training dataset was used to train the deep learning model, which was validated and tested by the other two datasets.
|
|
development dataset 02
Slit-lamp and retinal fundus images collected from Affiliated Huadu Hospital of Southern Medical University.
|
The training dataset was used to train the deep learning model, which was validated and tested by the other two datasets.
|
|
development dataset 03
Slit-lamp and retinal fundus images collected from Nantian Medical Centre of Aikang Health Care.
|
The training dataset was used to train the deep learning model, which was validated and tested by the other two datasets.
|
|
test dataset 01
Slit-lamp and retinal fundus images collected from Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-sen University.
|
The training dataset was used to train the deep learning model, which was validated and tested by the other two datasets.
|
|
test dataset 02
Slit-lamp and retinal fundus images collected from Huanshidong Medical Centre of Aikang Health Care.
|
The training dataset was used to train the deep learning model, which was validated and tested by the other two datasets.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
area under the receiver operating characteristic curve of the deep learning system
Time Frame: baseline
|
The investigators will calculate the area under the receiver operating characteristic curve of deep learning system and compare this index between deep learning system and human doctors
|
baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
sensitivity and specificity of the deep learning system
Time Frame: baseline
|
The investigators will calculate the sensitivity and specifity of deep learning system and compare this index between deep learning system and human doctors
|
baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
December 1, 2018
Primary Completion (ACTUAL)
January 31, 2020
Study Completion (ACTUAL)
January 31, 2020
Study Registration Dates
First Submitted
December 25, 2019
First Submitted That Met QC Criteria
December 25, 2019
First Posted (ACTUAL)
December 30, 2019
Study Record Updates
Last Update Posted (ACTUAL)
August 18, 2020
Last Update Submitted That Met QC Criteria
August 16, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AEHD-2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Artificial Intelligence
-
Uşak UniversityCompletedDigital Competences | Artificial Intelligence (AI) | Physiotherapist Students | Acceptance of Artificial Intelligence | Artificial Intelligence AttitudeTurkey
-
University of YalovaNot yet recruitingArtificial Intelligence | Nursing Education | Clinical Competence | Artificial Intelligence (AI) | Nursing Process | Nursing Process Competence | Artificial Intelligence Perception and AttitudeTurkey (Türkiye)
-
Cambridge Health AllianceEnrolling by invitationAI (Artificial Intelligence) | Large Language Model | Generative Artificial IntelligenceUnited States
-
John J ChenCompletedCommunication | Interdisciplinary Communication | Artificial Intelligence (AI) | Artificial Intelligence TechnologyUnited States
-
Radboud University Medical CenterPrime Dental Alliance EindhovenNot yet recruitingArtificial Intelligence Supported Image Reviewing | Artificial Intelligence (AI) in DiagnosisNetherlands
-
Tanta UniversityNot yet recruitingArtificial Intelligence
-
Recep Tayyip Erdogan UniversityCompleted
-
Istituto Clinico HumanitasCompletedArtificial IntelligenceItaly
-
Istituto Clinico HumanitasCompletedArtificial IntelligenceItaly
-
Second Affiliated Hospital, School of Medicine,...UnknownArtificial IntelligenceChina
Clinical Trials on Hepatobiliary Disorders
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityThird Affiliated Hospital, Sun Yat-Sen University; Aikang Health CareCompletedSystemic Diseases | Ophthalmology | Hepatobiliary Diseases | Artificial Intelligence (AI)China
-
Beijing Tsinghua Chang Gung HospitalRecruitingPostoperative Complications | Liver Neoplasm | Hepatobiliary Diseases | Myocardial Injury After Noncardiac Surgery (MINS)China
-
University of AarhusCompletedHeart Failure | Stroke | Epilepsy | Pain | Multiple Sclerosis | Hypertension | Diabetes Mellitus | Cancer | Chronic Kidney Diseases | Schizophrenia | Parkinson Disease | Migraine | Inflammatory Bowel Diseases | Anemia | HIV/AIDS | Atrial Fibrillation | Dyslipidemias | Allergy | Osteoporosis | Ischemic Heart Disease | Hearing Disorders | Substance... and other conditions
-
Hospital Italiano de Buenos AiresCompleted
-
University Hospital, LilleMinistry of Health, FranceCompletedHepatic InsufficiencyFrance
-
Konya Meram State HospitalCompleted
-
University Hospital of North NorwayUniversity of TromsoCompleted
-
Tampere University HospitalTampere University; Coxa, Hospital for Joint ReplacementCompletedDelirium | Cognitive Impairment | Malnutrition | Dementia
-
Universitat Jaume IMinisterio de Economía y Competitividad, SpainUnknownOnline Computerized Program Group | Waiting List Control GroupSpain
-
University Hospital, Clermont-FerrandCompletedParkinson Disease | Restless Leg SyndromeFrance